Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents

© 2018 International Medical Press. Background: Rilpivirine (RPV), a non-nucleoside reverse transcriptase inhibitor drug, could be a favourable drug for maintenance therapy in HIV-infected adolescents because it has few long-term side effects. However, data among adolescents switching from efavirenz...

全面介紹

Saved in:
書目詳細資料
Main Authors: Watsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, Narukjaporn Thammajaruk, Jiratchaya Sophonphan, Torsak Bunupuradah, Tim R. Cressey, Angela Colbers, David M. Burger, Wanatpreeya Phongsamart, Thanyawee Puthanakit, Chitsanu Pancharoen
格式: 雜誌
出版: 2018
主題:
Medicine
Pharmacology, Toxicology and Pharmaceutics
在線閱讀:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85051217524&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/59058
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Chiang Mai University

因特網

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85051217524&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/59058

相似書籍